APW
EXAS

Aventura Private Wealth’s Exact Sciences EXAS Stock Holding History

Aventura Private Wealth’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-90
Closed -$9.14K – 916
2025
Q4 		$9.14K Hold
90
– – ﹤0.01% 517
2025
Q3 		$4.92K Sell
90
-15
-14% -$749 ﹤0.01% 588
2025
Q2 		$5.58K Hold
105
– – ﹤0.01% 533
2025
Q1 		$4.54K Hold
105
– – ﹤0.01% 536
2024
Q4 		$5.9K Buy
+105
New +$6.53K ﹤0.01% 496

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Aventura Private Wealth's EXAS Position: Q1 2026 in Review

Aventura Private Wealth sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 90 shares — an estimated $9.14K sold.

Aventura Private Wealth first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $9.14K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Aventura Private Wealth reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Aventura Private Wealth sold 90 Exact Sciences shares in Q1 2026, an estimated $9.14K.
  • Aventura Private Wealth first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
  • Aventura Private Wealth's Exact Sciences position peaked at $9.14K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Aventura Private Wealth's 13F filing for Q1 2026, filed 6 May 2026.